Evidence map›Paper›PMID 24637710›Full record

ArticleBioengineered

Use of bio-mimetic three-dimensional technology in therapeutics for heart disease.

Vahid Serpooshan, Mingming Zhao, Scott A Metzler, Ke Wei, Parisha B Shah, Andrew Wang, Morteza Mahmoudi, Andrey V Malkovskiy, Jayakumar Rajadas, Manish J Butte and 2 more

Open access · goldAbstract read
In one paragraph

Article in Bioengineered. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Image-Guided Cardiac Regeneration via a 3D Bioprinted Vascular Patch with Built-in CT Visibility.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Adhesive Tissue Engineered Scaffolds: Mechanisms and Applications.Frontiers in bioengineering and biotechnology · 2021
    Review
  9. Review
  10. Extracellular Matrix in Ischemic Heart Disease, Part 4/4: JACC Focus Seminar.Journal of the American College of Cardiology · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Vahid SerpooshanStanford University; Department of Pediatrics; Stanford, CA USA.
Mingming ZhaoStanford University; Department of Pediatrics; Stanford, CA USA.
Scott A MetzlerStanford University; Department of Pediatrics; Stanford, CA USA.
Ke WeiSanford-Burnham Medical Research Institute; La Jolla, CA USA.
Parisha B ShahStanford University; Department of Pediatrics; Stanford, CA USA.
Andrew WangStanford University; Department of Pediatrics; Stanford, CA USA.
Morteza MahmoudiStanford University; Department of Pediatrics; Stanford, CA USA.
Andrey V MalkovskiyStanford University; Biomaterials and Advanced Drug Delivery Laboratory; Stanford, CA USA.
Jayakumar RajadasStanford University; Biomaterials and Advanced Drug Delivery Laboratory; Stanford, CA USA.
Manish J ButteStanford University; Department of Pediatrics; Stanford, CA USA.
Daniel BernsteinStanford University; Department of Pediatrics; Stanford, CA USA.
Pilar Ruiz-LozanoStanford University; Department of Pediatrics; Stanford, CA USA; Sanford-Burnham Medical Research Institute; La Jolla, CA USA.
Stanford University · USLa Jolla Alcohol Research · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Training in Myocardial Biology at Stanford (TIMBS)T32HL094274 · NHLBI · STANFORD UNIVERSITY · PI Euan A Ashley, Daniel Bernstein · 2010 to 2026
$5.0M
NHLBI NIH HHS T32 HL094274
6 · The paper itself

Abstract

Due to the limited self-renewal capacity of cardiomyocytes, the mammalian heart exhibits impaired regeneration and insufficient ability to restore heart function after injury. Cardiovascular tissue engineering is currently considered as a promising alternative therapy to restore the structure and function of the failing heart. Recent evidence suggests that the epicardium may play critical roles in regulation of myocardial development and regeneration. One of the mechanisms that has been proposed for the restorative effect of the epicardium is the specific physiomechanical cues that this layer provides to the cardiac cells. In this article we explore whether a new generation of epicardium-mimicking, acellular matrices can be utilized to enhance cardiac healing after injury. The matrix consists of a dense collagen scaffold with optimized biomechanical properties approaching those of embryonic epicardium. Grafting the epicardial patch onto the ischemic myocardium--promptly after the incidence of infarct--resulted in preserved contractility, attenuated ventricular remodeling, diminished fibrosis, and vascularization within the injured tissue in the adult murine heart.

Indexed as

Implants, ExperimentalAnimalsBiomimetic MaterialsCell ProliferationCollagenElastic ModulusEmbryo, MammalianEpithelial CellsFibrosisGelsMaleMiceMyocardial ContractionMyocardial InfarctionMyocytes, CardiacNeovascularization, PhysiologicCollagenGelsangiogenesiscardiac tissue engineeringcardiomyocytecollagenheartmyocardial infarctionscaffold

Identifiers

PMID24637710
PMCPMC4101012
OpenAlexW2070780919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.